ECSP13012409A - Derivados de amina cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4 - Google Patents
Derivados de amina cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4Info
- Publication number
- ECSP13012409A ECSP13012409A ECSP13012409A ECSP13012409A EC SP13012409 A ECSP13012409 A EC SP13012409A EC SP13012409 A ECSP13012409 A EC SP13012409A EC SP13012409 A ECSP13012409 A EC SP13012409A
- Authority
- EC
- Ecuador
- Prior art keywords
- pain
- cis
- derivatives
- ciclohexan
- espiro
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 108010020615 nociceptin receptor Proteins 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010065390 Inflammatory pain Diseases 0.000 abstract 1
- 102000048266 Nociceptin Human genes 0.000 abstract 1
- 208000001294 Nociceptive Pain Diseases 0.000 abstract 1
- 108090000137 Opioid Receptors Proteins 0.000 abstract 1
- 102000003840 Opioid Receptors Human genes 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010045171 Tumour pain Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- RERZNCLIYCABFS-UHFFFAOYSA-N harmaline Chemical compound C1CN=C(C)C2=C1C1=CC=C(OC)C=C1N2 RERZNCLIYCABFS-UHFFFAOYSA-N 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- PULGYDLMFSFVBL-SMFNREODSA-N nociceptin Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 PULGYDLMFSFVBL-SMFNREODSA-N 0.000 abstract 1
- 208000009935 visceral pain Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invención se refiere a los derivados de amina cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4, los cuales tienen efecto sobre el sistema de nociceptina/ receptor ORL-1 y también sobre el sistema receptor opioide µ, y que se presentan de manera más específica, por medio de una eficacia selectiva en el tratamiento del dolor crónico (entre otros, el dolor inflamatorio, el dolor visceral, el dolor de tumores, de preferencia, el dolor neuropático), sin mostrar al mismo tiempo una eficacia pronunciada en el dolor nociceptivo agudo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10007822 | 2010-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP13012409A true ECSP13012409A (es) | 2013-06-28 |
Family
ID=44315152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP13012409 ECSP13012409A (es) | 2010-07-28 | 2013-01-28 | Derivados de amina cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4 |
Country Status (31)
| Country | Link |
|---|---|
| US (3) | US20120029006A1 (es) |
| EP (2) | EP2740476B1 (es) |
| JP (1) | JP5898193B2 (es) |
| KR (1) | KR101927054B1 (es) |
| CN (1) | CN103025732B (es) |
| AR (1) | AR082393A1 (es) |
| AU (1) | AU2011285217B8 (es) |
| BR (1) | BR112013003642A2 (es) |
| CA (1) | CA2806633C (es) |
| CL (1) | CL2013000266A1 (es) |
| CO (1) | CO6650378A2 (es) |
| CY (2) | CY1115186T1 (es) |
| DK (2) | DK2740476T3 (es) |
| EC (1) | ECSP13012409A (es) |
| ES (2) | ES2708930T3 (es) |
| HR (2) | HRP20140569T1 (es) |
| HU (1) | HUE042732T2 (es) |
| IL (1) | IL223756A (es) |
| LT (1) | LT2740476T (es) |
| MX (1) | MX2013000751A (es) |
| NZ (1) | NZ607529A (es) |
| PE (1) | PE20130808A1 (es) |
| PL (2) | PL2740476T3 (es) |
| PT (2) | PT2740476T (es) |
| RS (2) | RS58036B1 (es) |
| RU (1) | RU2592283C2 (es) |
| SI (2) | SI2740476T1 (es) |
| TR (1) | TR201821273T4 (es) |
| TW (1) | TWI582092B (es) |
| WO (1) | WO2012013343A1 (es) |
| ZA (1) | ZA201301505B (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015022509A2 (pt) * | 2013-03-15 | 2017-07-18 | Gruenenthal Gmbh | forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina |
| US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
| US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
| SI3402782T1 (sl) | 2016-01-13 | 2020-11-30 | Grunenthal Gmbh | 8-amino-2-okso-1,3-diaza-spiro-(4,5)-dekanski derivati |
| CA3011176C (en) | 2016-01-13 | 2023-09-19 | Grunenthal Gmbh | 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| CA3011180A1 (en) * | 2016-01-13 | 2017-07-20 | Grunenthal Gmbh | 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives |
| SI3402784T1 (sl) | 2016-01-13 | 2020-07-31 | Gruenenthal Gmbh | Derivati 3-((hetero)aril)-alkil-8-amino-2-okso-1,3-diaza-spiro-(4.5)-dekana |
| BR112018014302B1 (pt) | 2016-01-13 | 2023-10-17 | Grünenthal GmbH | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano |
| PL3838274T3 (pl) | 2016-01-26 | 2024-04-02 | Intra-Cellular Therapies, Inc. | Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN |
| TW201832765A (zh) * | 2017-02-24 | 2018-09-16 | 德商歌林達有限公司 | 膀胱內投藥用於治療膀胱痛之組合物 |
| TW201908295A (zh) | 2017-07-12 | 2019-03-01 | 德商歌林達有限公司 | １，３－二氮雜－螺－［３．４］－辛烷衍生物 |
| JP2019073493A (ja) * | 2017-10-17 | 2019-05-16 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | ヴルヴォディニアの治療 |
| CN112040940A (zh) | 2018-03-23 | 2020-12-04 | 细胞内治疗公司 | 有机化合物 |
| WO2020030777A1 (en) | 2018-08-10 | 2020-02-13 | Grünenthal GmbH | Composition for treating urinary frequency and/or urinary urgency |
| JP7520013B2 (ja) | 2018-12-17 | 2024-07-22 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 置換複素環縮合γ－カルボリンの合成 |
| WO2020131899A1 (en) | 2018-12-17 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compound |
| US12195463B2 (en) | 2018-12-21 | 2025-01-14 | Intra-Cellular Therapies, Inc. | Organic compounds |
| JP7649743B2 (ja) | 2018-12-21 | 2025-03-21 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| CA3134674A1 (en) * | 2019-04-04 | 2020-10-08 | Intra-Cellular Therapies, Inc. | Methods of treating neuropathic pain |
| CN119241381A (zh) | 2019-12-26 | 2025-01-03 | 吉尔伽美什制药公司 | 芳基环己基胺衍生物及其在精神障碍的治疗中的用途 |
| RU2725197C1 (ru) * | 2020-02-12 | 2020-06-30 | федеральное государственное бюджетное образовательное учреждение высшего образования «Ижевская государственная медицинская академия» Министерства здравоохранения Российской Федерации | Метод оценки висцеральной гиперчувствительности |
| KR20260008838A (ko) | 2020-02-18 | 2026-01-16 | 길가메쉬 파마슈티컬스, 인코포레이티드 | 기분 장애 치료에 사용되기 위한 특이적 트립타민 |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
| US12129234B1 (en) | 2023-08-03 | 2024-10-29 | Gilgamesh Pharmaceuticals, Inc. | Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| US12180158B1 (en) | 2023-08-03 | 2024-12-31 | Gilgamesh Pharmaceuticals, Inc. | Crystalline fumarate salts of n-ethyl-2-(5-fluoro-1H-indol-3-yl)-n-methylethan-1-amine |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10252667A1 (de) * | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10323172A1 (de) | 2003-05-22 | 2004-12-09 | Ina-Schaeffler Kg | Treiberstufe für ein Solenoidventil |
| DE10360792A1 (de) | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10360793A1 (de) * | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE102004019502A1 (de) | 2004-04-22 | 2005-11-17 | Rheinmetall Landsysteme Gmbh | Munitionsmagazin |
| DE102004039382A1 (de) | 2004-08-13 | 2006-02-23 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| US8425881B2 (en) | 2005-03-18 | 2013-04-23 | Colgate-Palmolive Company | Antibacterial 3′,5-disubstituted 2,4′-dihydroxybiphenyl compounds, derivatives and related methods |
| DE102005016460A1 (de) * | 2005-04-11 | 2006-10-19 | Grünenthal GmbH | Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit |
| WO2006110856A2 (en) | 2005-04-12 | 2006-10-19 | The Ohio State University | All wheel drive electrically-variable transmission |
| AU2007233564A1 (en) | 2006-03-30 | 2007-10-11 | Innovative Dairy Products Pty Ltd As Trustee For The Participants Of The Cooperative Research Centre For Innovative Dairy Products | Chromosomal blocks as markers for traits |
| WO2007117173A1 (en) | 2006-04-07 | 2007-10-18 | Closed Joint Stock Company 'biocad' | Fluid dispensing system, methods and products |
| DE102006019597A1 (de) * | 2006-04-27 | 2007-10-31 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE102006033114A1 (de) | 2006-07-18 | 2008-01-24 | Grünenthal GmbH | Spirocyclische Azaindol-Derivate |
| DE102006046745A1 (de) * | 2006-09-29 | 2008-04-03 | Grünenthal GmbH | Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz |
| WO2008100941A2 (en) | 2007-02-12 | 2008-08-21 | Correlogic Systems Inc. | A method for calibrating an analytical instrument |
| PT2260042E (pt) * | 2008-03-27 | 2011-12-06 | Gruenenthal Gmbh | Derivados de ciclo-hexano espirocíclicos substituídos |
| BR112015022509A2 (pt) * | 2013-03-15 | 2017-07-18 | Gruenenthal Gmbh | forma cristalina de cis-(e)-4-(3-fluorofenil)-2',3',4',9'-tetra-hidro-n,n-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1h]-pirido[3,4-b]indol]-4-amina cristalina |
-
2011
- 2011-06-22 TW TW100121735A patent/TWI582092B/zh not_active IP Right Cessation
- 2011-07-27 BR BR112013003642A patent/BR112013003642A2/pt not_active IP Right Cessation
- 2011-07-27 ES ES14000496T patent/ES2708930T3/es active Active
- 2011-07-27 DK DK14000496.1T patent/DK2740476T3/en active
- 2011-07-27 TR TR2018/21273T patent/TR201821273T4/tr unknown
- 2011-07-27 EP EP14000496.1A patent/EP2740476B1/de not_active Not-in-force
- 2011-07-27 RU RU2013108696/04A patent/RU2592283C2/ru active
- 2011-07-27 CN CN201180038485.8A patent/CN103025732B/zh not_active Expired - Fee Related
- 2011-07-27 RS RS20181491A patent/RS58036B1/sr unknown
- 2011-07-27 MX MX2013000751A patent/MX2013000751A/es active IP Right Grant
- 2011-07-27 PL PL14000496T patent/PL2740476T3/pl unknown
- 2011-07-27 PE PE2013000150A patent/PE20130808A1/es active IP Right Grant
- 2011-07-27 EP EP11737904.0A patent/EP2598503B1/de not_active Not-in-force
- 2011-07-27 DK DK11737904.0T patent/DK2598503T3/da active
- 2011-07-27 ES ES11737904.0T patent/ES2474644T3/es active Active
- 2011-07-27 NZ NZ607529A patent/NZ607529A/en not_active IP Right Cessation
- 2011-07-27 SI SI201131631T patent/SI2740476T1/sl unknown
- 2011-07-27 HU HUE14000496A patent/HUE042732T2/hu unknown
- 2011-07-27 PL PL11737904T patent/PL2598503T3/pl unknown
- 2011-07-27 KR KR1020137004985A patent/KR101927054B1/ko not_active Expired - Fee Related
- 2011-07-27 SI SI201130137T patent/SI2598503T1/sl unknown
- 2011-07-27 AR ARP110102711A patent/AR082393A1/es not_active Application Discontinuation
- 2011-07-27 PT PT14000496T patent/PT2740476T/pt unknown
- 2011-07-27 HR HRP20140569AT patent/HRP20140569T1/hr unknown
- 2011-07-27 LT LTEP14000496.1T patent/LT2740476T/lt unknown
- 2011-07-27 JP JP2013521013A patent/JP5898193B2/ja not_active Expired - Fee Related
- 2011-07-27 RS RS20140312A patent/RS53341B/sr unknown
- 2011-07-27 WO PCT/EP2011/003771 patent/WO2012013343A1/de not_active Ceased
- 2011-07-27 CA CA2806633A patent/CA2806633C/en not_active Expired - Fee Related
- 2011-07-27 PT PT117379040T patent/PT2598503E/pt unknown
- 2011-07-27 AU AU2011285217A patent/AU2011285217B8/en not_active Ceased
- 2011-07-28 US US13/192,641 patent/US20120029006A1/en not_active Abandoned
-
2012
- 2012-12-20 IL IL223756A patent/IL223756A/en active IP Right Grant
-
2013
- 2013-01-28 CO CO13014969A patent/CO6650378A2/es not_active Application Discontinuation
- 2013-01-28 CL CL2013000266A patent/CL2013000266A1/es unknown
- 2013-01-28 EC ECSP13012409 patent/ECSP13012409A/es unknown
- 2013-02-27 ZA ZA2013/01505A patent/ZA201301505B/en unknown
-
2014
- 2014-05-13 CY CY20141100338T patent/CY1115186T1/el unknown
-
2015
- 2015-09-04 US US14/846,155 patent/US20160159787A1/en not_active Abandoned
-
2017
- 2017-07-19 US US15/654,389 patent/US20170313703A1/en not_active Abandoned
-
2018
- 2018-12-10 HR HRP20182078TT patent/HRP20182078T1/hr unknown
- 2018-12-12 CY CY181101335T patent/CY1120993T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP13012409A (es) | Derivados de amina cis-tetrahidro-espiro(ciclohexan-1,1'-pirido[3,4-b]indol)-4 | |
| CY1123427T1 (el) | Kpyσtaλλikeς mopφeς δiamopφωτη yποδoxea anδpoγonωn | |
| GT201200247A (es) | Formulaciones orales y sales lipofílicas de metilnaltrexona | |
| MY160665A (en) | Spiropiperidine compounds as orl-1 receptor antagonists | |
| BRPI0907257A2 (pt) | Sistema e métodos para estimulação elétrica terapêutica | |
| EA201491607A1 (ru) | Модуляторы толлподобных рецепторов | |
| MX2012004157A (es) | 8-etil-6-(aril)pirido[2.3-d]pirimidin-7(8h)-onas para el tratamiento de trastornos del snc. | |
| EA201290355A1 (ru) | Спиропиперидиновые соединения в качестве антагонистов рецептора orl-1 | |
| EA201270467A1 (ru) | Полициклические соединения в качестве антагонистов рецепторов лизофосфатидной кислоты | |
| SI2547679T1 (sl) | Derivati 2,3 dihidro-1H-inden-1-il-2,7-diazaspiro(3.6)nonana in njihova uporaba kot antagonisti ali inverzni agonisti grelinskega receptorja | |
| PT2726141T (pt) | Dispositivo para administração oral de compostos terapêuticos | |
| CR20120265A (es) | Combinaciones de un antagonista de los receptores muscarínicos y un agonista del adreno-receptor beta-2 | |
| SI2379511T1 (sl) | Substituirani diketopiperazinski analogi za uporabo kot sredstva za dostavo zdravil | |
| BR112013014854A2 (pt) | compostos de n-(1h-indazol-4-il)midazo [1,2-a] piridina-3-carboxamida substituídos como inibidores de tirosina quinase de receptor tipo iii | |
| DK4098256T3 (da) | Doseringsregime for en s1p-receptoragonist | |
| EA201190142A1 (ru) | Производные пиразола, используемые в качестве антагонистов рецептора ccr4 | |
| SI2820016T1 (sl) | N-(5s,6s,9r)-5-amino-6-(2,3-difluorofenil)-6,7,8,9-tetrahidro-5h- ciklohepta (b)piridin-9-il-4-(2-okso-2, 3-dihidro-1h-imidazo(4,5-b) piridin-1-il) piperidin-1-karboksilat, hemisulfatna sol | |
| DK2491028T3 (da) | Indazol og pyrazolopyridine forbindelser som CCR1 receptor antagonister | |
| BR112013012117A2 (pt) | sistema de distribuição de fármacos iontoforético coempacotado autocontido ativado por usuário | |
| BRPI0923698A2 (pt) | "sistema de elevador com um dispositivo de segurança" | |
| IL248839A0 (en) | Translation: compounds containing 1,1',2,5'-tetrahydrospiro[indole-3-2'-pyrrole]-2,5'-dione system as inhibitors of p53-mdm2 protein-protein interaction | |
| CR20120068A (es) | Formulaciones de imiquimod de concentración de dosificación inferior y regímenes de dosificación cortos para tratar verrugas genitales y perianales | |
| AR075260A1 (es) | Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos | |
| ATE537143T1 (de) | Spiro(5.5)undecan derivate | |
| CY1118132T1 (el) | ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ (1R,4R)-6'-ΦΘΟΡΟ-Ν,Ν-ΔΙΜΕΘΥΛ-4-ΦΑΙΝΥΛ-4',9'-ΔΙΥΔΡΟ-3´H-ΣΠΕΙΡΟ-[ΚΥΚΛΟΕΞΑΝΟ-1,1'-ΠΥΡΑΝΟ[3,4,b]ΙΝΔΟΛ]-4-ΑΜΙΝΗΣ |